Black Diamond Therapeutics, Inc. (BDTX)
NASDAQ: BDTX · Real-Time Price · USD
2.430
-0.060 (-2.41%)
At close: Dec 31, 2025, 4:00 PM EST
2.420
-0.010 (-0.41%)
After-hours: Dec 31, 2025, 7:42 PM EST
BDTX Market Cap
BDTX has a market cap or net worth of $138.45 million as of December 31, 2025. Its market cap has decreased by -4.42% in one year.
Market Cap
138.45M
Enterprise Value
22.62M
1-Year Change
-4.42%
Ranking
Category
Stock Price
$2.43
Market Cap Chart
Since January 30, 2020, BDTX's market cap has decreased from $1.36B to $138.45M, a decrease of -89.78%. That is a compound annual growth rate of -31.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 31, 2025 | 138.45M | 14.33% |
| Dec 31, 2024 | 121.09M | -16.54% |
| Dec 29, 2023 | 145.09M | 121.66% |
| Dec 30, 2022 | 65.46M | -66.10% |
| Dec 31, 2021 | 193.10M | -83.26% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jan 30, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 966.79B |
| Johnson & Johnson | 498.51B |
| AbbVie | 406.04B |
| UnitedHealth Group | 300.88B |
| AstraZeneca | 287.28B |
| Novartis AG | 266.00B |
| Merck & Co. | 263.24B |
| Novo Nordisk | 227.63B |